Perfecting the production management system of Sihuan Pharmaceutical Holding Group

Beijing Sihuan Pharmaceutical Co., Ltd. is a domestic first-class production enterprise with management and construction. It has a modern production base certified by the National good manufacturing practice (GMP), including workshops for raw materials, solid preparations, small-volume injections, freeze-dried powder injections, hormone raw materials and oral preparations; With complete functions and strong production capacity, it can produce 7 dosage forms, such as tablets, capsules, granules, hormone tablets, small-volume injections, freeze-dried powder injections and raw materials. With hundreds of production equipment and testing instruments, the automation level is leading in China. Production quality management has been highly praised by national and local drug supervision and management departments; The company's products are of excellent quality and well received by consumers.

Company honor:

☆ Won the high-tech enterprise in Beijing;

☆ Tongzhou District of Beijing was rated as a big taxpayer in 2006;

☆ In 2007, he was awarded Grade A tax credit in Beijing.

Six, standardized financial management system and healthy financial structure

Perfect budget and final accounts system, reporting system, income management system, expenditure management system, fund management system and performance evaluation system, and strict and standardized financial management have enabled the Group to maintain a healthy financial structure and won favorable comments from the industrial and commercial tax administration departments.

A healthy financial structure is not only reflected in the continuous growth of business every year, but also in excellent profitability, good cash liquidity and asset liquidity.

Sihuan Group adheres to its business philosophy and corporate purpose with firm belief, wise vision and professional spirit. Products are the source power, marketing is the traction, capital management is the power, and industrial management and capital management are combined. Focusing on the field of cardiovascular and cerebrovascular drugs, with the mission of serving human health, we are determined to become the most competitive international enterprise integrating R&D, production and marketing of cardiovascular and cerebrovascular drugs.